Market Overview

Baxter Acquires Dialysis Product Company Gambro


Baxter International Inc. (NYSE: BAX) has entered into a definitive
agreement to acquire Gambro AB, a privately held dialysis product
company based in Lund, Sweden, for total consideration of 26.5 billion
SEK (approximately $4.0 billion USD at current exchange rates). Gambro
is a global medical technology company focused on developing,
manufacturing and supplying dialysis products and therapies for patients
with acute or chronic kidney disease. The acquisition gives Baxter a
comprehensive dialysis product portfolio, complements Baxter's global
home dialysis offerings, and positions the company to better meet the
evolving needs of the large and growing dialysis market.

''Baxter has a legacy of innovation in dialysis, including the
development of peritoneal dialysis for the treatment of

See full press release

Posted-In: News Guidance Management M&A Global


Related Articles (BAX)

View Comments and Join the Discussion!